Chargement en cours...
Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis
Background: Dalfampridine extended release (ER) improves walking in people with multiple sclerosis (MS), as demonstrated by walking speed improvement. This exploratory study evaluated treatment effects of dalfampridine-ER on gait, balance, and walking through treatment withdrawal and reinitiation. M...
Enregistré dans:
| Publié dans: | Int J MS Care |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The Consortium of Multiple Sclerosis Centers
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4673920/ https://ncbi.nlm.nih.gov/pubmed/26664333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7224/1537-2073.2014-036 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|